{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:16:58Z","timestamp":1775607418455,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11060-013-1233-0","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T04:46:43Z","timestamp":1378270003000},"page":"317-322","source":"Crossref","is-referenced-by-count":73,"title":["Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature"],"prefix":"10.1007","volume":"115","author":[{"given":"Daniel","family":"Lubelski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalil G.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas F.","family":"Marko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"issue":"10","key":"1233_CR1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"2","key":"1233_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00701-011-1228-6","volume":"154","author":"A Siu","year":"2012","unstructured":"Siu A, Wind JJ, Iorgulescu JB et al (2012) Radiation necrosis following treatment of high grade glioma\u2014a review of the literature and current understanding. Acta Neurochir (Wien) 154(2):191\u2013201 discussion 201","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"1233_CR3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.nrl.0000080951.78533.c4","volume":"9","author":"P Giglio","year":"2003","unstructured":"Giglio P, Gilbert MR (2003) Cerebral radiation necrosis. Neurologist 9(4):180\u2013188","journal-title":"Neurologist"},{"issue":"6","key":"1233_CR4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3171\/jns.2001.94.6.0899","volume":"94","author":"LS Chin","year":"2001","unstructured":"Chin LS, Ma L, DiBiase S (2001) Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 94(6):899\u2013904","journal-title":"J Neurosurg"},{"issue":"5","key":"1233_CR5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","volume":"9","author":"D Brandsma","year":"2008","unstructured":"Brandsma D, Stalpers L, Taal W, Sminia P, Van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9(5):453\u2013461","journal-title":"Lancet Oncol"},{"issue":"1","key":"1233_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-006-9241-y","volume":"82","author":"MC Chamberlain","year":"2007","unstructured":"Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE (2007) Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82(1):81\u201383","journal-title":"J Neurooncol"},{"issue":"3","key":"1233_CR7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11864-011-0157-1","volume":"12","author":"J Fink","year":"2011","unstructured":"Fink J, Born D, Chamberlain MC (2011) Pseudoprogression: relevance with respect to treatment of high-grade gliomas. Curr Treat Options Oncol 12(3):240\u2013252","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"1233_CR8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1215\/15228517-2008-008","volume":"10","author":"AA Brandes","year":"2008","unstructured":"Brandes AA, Tosoni A, Spagnolli F et al (2008) Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro Oncol 10(3):361\u2013367","journal-title":"Neuro Oncol"},{"issue":"2","key":"1233_CR9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2005.12.002","volume":"65","author":"JD Ruben","year":"2006","unstructured":"Ruben JD, Dally M, Bailey M et al (2006) Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65(2):499\u2013508","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1233_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2047-783X-17-25","volume":"17","author":"Y Wang","year":"2012","unstructured":"Wang Y, Pan L, Sheng X et al (2012) Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res 17(1):25","journal-title":"Eur J Med Res"},{"key":"1233_CR11","doi-asserted-by":"crossref","unstructured":"Drappatz J, Schiff D, Kesari S, Norden AD, Wen PY (2007) Medical management of brain tumor patients. Neurol Clin 25(4):1035\u20131071, ix","DOI":"10.1016\/j.ncl.2007.07.015"},{"issue":"6","key":"1233_CR12","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/1097-0142(197606)37:6<2580::AID-CNCR2820370603>3.0.CO;2-H","volume":"37","author":"GB Hart","year":"1976","unstructured":"Hart GB, Mainous EG (1976) The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer 37(6):2580\u20132585","journal-title":"Cancer"},{"issue":"10","key":"1233_CR13","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<2005::AID-CNCR19>3.0.CO;2-0","volume":"80","author":"PJ Chuba","year":"1997","unstructured":"Chuba PJ, Aronin P, Bhambhani K et al (1997) Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 80(10):2005\u20132012","journal-title":"Cancer"},{"issue":"1\u20132","key":"1233_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-510X(03)00007-8","volume":"209","author":"K Kohshi","year":"2003","unstructured":"Kohshi K, Imada H, Nomoto S et al (2003) Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy. J Neurol Sci 209(1\u20132):115\u2013117","journal-title":"J Neurol Sci"},{"issue":"3","key":"1233_CR15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijrobp.2004.04.019","volume":"60","author":"Q-C Bui","year":"2004","unstructured":"Bui Q-C, Lieber M, Withers HR et al (2004) The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects. Int J Radiat Oncol Biol Phys 60(3):871\u2013878","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"1233_CR16","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1212\/WNL.44.11.2020","volume":"44","author":"MJ Glantz","year":"1994","unstructured":"Glantz MJ, Burger PC, Friedman AH et al (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44(11):2020\u20132027","journal-title":"Neurology"},{"issue":"2","key":"1233_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","volume":"67","author":"J Gonzalez","year":"2007","unstructured":"Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67(2):323\u2013326","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1233_CR18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA, Bidaut L, Hou P et al (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79(5):1487\u20131495","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1233_CR19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00066-010-2184-4","volume":"187","author":"C Matuschek","year":"2011","unstructured":"Matuschek C, B\u00f6lke E, Nawatny J et al (2011) Bevacizumab as a treatment option for radiation-induced cerebral necrosis. Strahlenther Onkol 187(2):135\u2013139","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"1233_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nrl.2010.05.010","volume":"26","author":"I Arratibel-Echarren","year":"2011","unstructured":"Arratibel-Echarren I, Albright K, Dalmau J, Rosenfeld MR (2011) Use of bevacizumab for neurological complications during initial treatment of malignant gliomas. Neurologia 26(2):74\u201380","journal-title":"Neurologia"},{"issue":"1","key":"1233_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-009-9801-z","volume":"94","author":"R Torcuator","year":"2009","unstructured":"Torcuator R, Zuniga R, Mohan YS et al (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94(1):63\u201368","journal-title":"J Neurooncol"},{"issue":"3","key":"1233_CR22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11060-010-0333-3","volume":"102","author":"M Furuse","year":"2011","unstructured":"Furuse M, Kawabata S, Kuroiwa T, Miyatake S-I (2011) Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases. J Neurooncol 102(3):471\u2013475","journal-title":"J Neurooncol"},{"issue":"4","key":"1233_CR23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neurol.2010.10.012","volume":"167","author":"S Gronier","year":"2011","unstructured":"Gronier S, Bourg V, Frenay M et al (2011) Bevacizumab for the treatment of cerebral radionecrosis. Rev Neurol (Paris) 167(4):331\u2013336","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"1233_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/WNL.0b013e318204a3af","volume":"76","author":"EM Thompson","year":"2011","unstructured":"Thompson EM, Frenkel EP, Neuwelt EA (2011) The paradoxical effect of bevacizumab in the therapy of malignant gliomas. Neurology 76(1):87\u201393","journal-title":"Neurology"},{"issue":"3","key":"1233_CR25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11060-010-0336-0","volume":"102","author":"PJ Kelly","year":"2011","unstructured":"Kelly PJ, Dinkin MJ, Drappatz J, O\u2019Regan KN, Weiss SE (2011) Unexpected late radiation neurotoxicity following bevacizumab use: a case series. J Neurooncol 102(3):485\u2013490","journal-title":"J Neurooncol"},{"issue":"22","key":"1233_CR26","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/WNL.0b013e3181c3fd00","volume":"73","author":"JH Sherman","year":"2009","unstructured":"Sherman JH, Aregawi DG, Lai A et al (2009) Optic neuropathy in patients with glioblastoma receiving bevacizumab. Neurology 73(22):1924\u20131926","journal-title":"Neurology"},{"key":"1233_CR27","author":"E Galanis","year":"2013","unstructured":"Galanis E, Anderson SK, Lafky JM, Uhm J, Giannini C, Kumar SK et al (2013) Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): A North Central Cancer Treatment Group Trial. Clin Cancer Res. doi: 10.1158\/1078-0432.CCR-13-0708","journal-title":"Clin Cancer Res"},{"key":"1233_CR28","unstructured":"Fleming T (ed) (2007) Red book: pharmacy\u2019s fundamental reference, 111th ed. Thomson, Belmont"},{"issue":"4","key":"1233_CR29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hec.1481","volume":"19","author":"T Shiroiwa","year":"2010","unstructured":"Shiroiwa T, Sung Y-K, Fukuda T et al (2010) International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 19(4):422\u2013437","journal-title":"Health Econ"},{"issue":"2","key":"1233_CR30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1212\/01.CON.0000413667.65668.ae","volume":"18","author":"EJ Dropcho","year":"2012","unstructured":"Dropcho EJ (2012) Should the cost of care for patients with glioblastoma influence treatment decisions? Continuum (Minneap Minn) 18(2):416\u2013420","journal-title":"Continuum (Minneap Minn)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1233-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-013-1233-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1233-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:17:44Z","timestamp":1559362664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-013-1233-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1233"],"URL":"https:\/\/doi.org\/10.1007\/s11060-013-1233-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}